Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
The EASL Podcast collection includes educational podcasts and audio versions of digital EASL offerings. The ASK EASL Podcasts: Ongoing series of educational podcasts. EASL Studio: Your weekly hepatology broadcast news.
Episode | Date |
---|---|
EASL Studio Podcast: YI Choice: Citizen science: Societal engagement in hepatology
|
Mar 28, 2024 |
EASL Studio Podcast: Therapy hierarchy in HCC: A new kid on the block
|
Mar 21, 2024 |
EASL Studio Podcast: Is there a role for measuring blood ammonia in patients with cirrhosis?
|
Mar 14, 2024 |
EASL Studio Podcast: The impact of policy measure in preventing liver diseases: The Hepahealth II study
|
Mar 07, 2024 |
EASL Studio Podcast: Alpha-1-antitrypsin deficiency (AATD): A poster child for genetic therapy
|
Feb 29, 2024 |
EASL Studio Podcast: JHEP Live: Should the compensated advanced chronic liver disease (cACLD) concept replace cirrhosis?
|
Feb 22, 2024 |
EASL Studio Podcast: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond
|
Feb 15, 2024 |
EASL Studio Podcast: How to stop recurrent bleeding due to small-intestinal angiodysplasia?
|
Feb 08, 2024 |
EASL Studio Podcast: Do we solve MASLD by treating obesity?
|
Jan 25, 2024 |
EASL Studio Podcast: EASL Studio’s holiday reflection: A look back to leap forward
|
Dec 21, 2023 |
EASL Studio Podcast: Hepatic encephalopathy: Underdiagnosed and underestimated
|
Dec 14, 2023 |
EASL Studio Podcast: Basics in decision-making for liver cancer treatment
|
Dec 07, 2023 |
EASL Studio Podcast: PSC and AIH overlap syndrome: does it actually exist?
|
Nov 30, 2023 |
EASL Studio Podcast: The window hypothesis again, or just a closed window?
|
Nov 23, 2023 |
EASL Studio Podcast: Why should diabetologists care about the liver?
|
Nov 16, 2023 |
EASL Studio Podcast: Alcohol and the new nomenclature – A game-changer?
|
Nov 09, 2023 |
JHEP Live: Hepatitis delta’s latest debate: Updates straight from EASL’s slate
|
Nov 02, 2023 |
EASL Studio Podcast: Why bother with diet and exercise when an injection will suffice?
|
Oct 19, 2023 |
EASL Studio Podcast: YI Choice: When stars fade: The untold story of burnout in academia
|
Oct 12, 2023 |
EASL Studio Podcast: JHEP Live: The new nomenclature for SLD: A multidisciplinary evaluation and approach
|
Oct 05, 2023 |
EASL Studio Podcast: Highlights from the EASL SLD Summit 2023
|
Sep 27, 2023 |
EASL Studio Podcast: Zoonotic Hepatitis E – What’s hot in 2023?
|
Sep 21, 2023 |
EASL Studio Podcast: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways
|
Sep 14, 2023 |
EASL Studio Podcast: What is really new in the EASL CPG on ACLF?
|
Sep 07, 2023 |
EASL Studio Podcast: United we stand: Global societies collaborating to beat liver disease
|
Aug 18, 2023 |
EASL Studio Podcast: Practice changing highlights from EASL Congress 2023
|
Aug 17, 2023 |
EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature
|
Aug 17, 2023 |
EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy
|
Aug 17, 2023 |
EASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023
|
Aug 17, 2023 |
EASL Studio Podcast: EASL Congress 2023: Back to the future
|
Aug 17, 2023 |
EASL Studio Podcast: The conundrum of NASH: The growing global disease burden with low disease awareness
|
Jun 15, 2023 |
EASL Studio Podcast: JHEP Live: New and promising drugs for NASH on the horizon
|
Jun 08, 2023 |
EASL Studio Podcast: Why you should stop smoking if you love your liver
|
Jun 01, 2023 |
EASL Studio Podcast: COST Actions: Opportunities for pan-European collaborations in liver diseases
|
May 25, 2023 |
EASL Studio Podcast: Promoting Liver Health: An urgent call for action at WHO
|
May 24, 2023 |
EASL Studio Podcast: HDV: The devil becomes treatable
|
May 19, 2023 |
EASL Studio Podcast: Liver nurses in Europe: Are there enough and can they do more?
|
May 11, 2023 |
EASL Studio Podcast: Albumin in cirrhosis: For all, for some, for none
|
May 04, 2023 |
EASL Studio Podcast: Highlights from the EASL Liver Cancer Summit 2023
|
Apr 27, 2023 |
EASL Studio Podcast: Diagnostic and therapeutic challenges in Wilson’s disease
|
Apr 20, 2023 |
EASL Studio Podcast: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance
|
Apr 19, 2023 |
EASL Studio Podcast: EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure
|
Apr 13, 2023 |
EASL Studio Podcast: JHEP Live: Liver transplantation for alcohol-related hepatitis
|
Apr 06, 2023 |
EASL Studio Podcast: NAFLD and NASH – moving beyond the liver biopsy – where are we now?
|
Mar 30, 2023 |
EASL Studio Podcast: YI Choice: Gene therapy for liver disease — RNA interference and beyond
|
Mar 23, 2023 |
EASL Studio Podcast: Ascites: New solution for an old problem?
|
Mar 16, 2023 |
EASL Studio Podcast: YI Choice: Gender equality in academics — reducing the gap
|
Mar 09, 2023 |
EASL Studio Podcast: Alcohol and food policies
|
Mar 02, 2023 |
EASL Studio Podcast: Regenerating the liver graft with a machine?
|
Feb 16, 2023 |
EASL Studio Podcast: AI for Dummies
|
Feb 09, 2023 |
EASL Studio Podcast: JHEP Live: Is the term ‘decompensated cirrhosis’ outdated?
|
Feb 02, 2023 |
EASL Studio Podcast: A 360 approach to beat alcohol-related liver disease
|
Jan 26, 2023 |
EASL Studio Podcast: YI Choice: How to build consortia and registries
|
Jan 19, 2023 |
EASL Studio Podcast: Hepatitis B elimination: How far behind are we and what do we need to change to achieve it?
|
Jan 12, 2023 |
EASL Studio Podcast: Liver cancer in 2022: Wrap-up & outlook
|
Dec 22, 2022 |
EASL Studio Podcast: Chronic portal vein thrombosis: Anticoagulation and interventional radiology for all patients?
|
Dec 15, 2022 |
EASL Studio Podcast: The future of hepatology
|
Dec 08, 2022 |
EASL Studio Podcast: Next-generation metrics for science beyond Journal impact factor and citations: The role of social media
|
Dec 01, 2022 |
EASL Studio Podcast: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within
|
Nov 24, 2022 |
EASL Studio Podcast: Regenerative Hepatology: From stem cells to tissue engineering
|
Nov 17, 2022 |
EASL Studio Podcast: JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?
|
Nov 03, 2022 |
EASL Studio Podcast: Transplanting patients with cancer – Is there a limit?
|
Oct 31, 2022 |
EASL Studio Podcast: Bugs and the liver — The role of the gut microbiome in liver diseases
|
Oct 20, 2022 |
EASL Studio Podcast: How to improve end-of-life care in liver disease?
|
Oct 13, 2022 |
EASL Studio Podcast: JHEP Live: Stigma and alcohol
|
Oct 06, 2022 |
EASL Studio Podcast: Special Edition: Highlights of EASL NAFLD Summit 2022
|
Sep 29, 2022 |
EASL Studio Podcast: Liver transplantation for ACLF: Opportunities, challenges and pitfalls
|
Sep 15, 2022 |
EASL Studio Podcast: JHEP Live: Covid vaccination and associated autoimmune hepatitis
|
Sep 09, 2022 |
EASL Studio Podcast: Teatime - 23 June 2022
|
Jul 07, 2022 |
EASL Studio Podcast: Teatime - 25 June 2022
|
Jul 07, 2022 |
EASL Studio Podcast: Teatime - 24 June 2022
|
Jul 07, 2022 |
EASL Studio Podcast: Teatime - 22 June 2022
|
Jul 07, 2022 |
EASL Studio Podcast: Midday Talks on Improving Liver Cancer Care and Prevention - 23 June 2022
|
Jul 07, 2022 |
EASL Studio Podcast: How can our response to the climate crisis transform and improve hepatology services?
|
Jun 30, 2022 |
EASL Studio Podcast: EASL Haemochromatosis Guidelines 2022
|
Jun 16, 2022 |
EASL Studio Podcast: JHEP Live on the best animal model for HCC – Lost in translation?
|
Jun 02, 2022 |
EASL Studio Podcast : Digital Pathology
|
May 20, 2022 |
EASL Studio Podcast: Nurse and AHP Focus: Sustainable Hepatology – Insights in nursing initiatives
|
May 11, 2022 |
EASL Studio Podcast - YI Choice: Propelling liver cell biology into the third dimension
|
Apr 21, 2022 |
EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?
|
Apr 05, 2022 |
EASL Studio Podcast: New era for science dissemination: The role of social media
|
Apr 05, 2022 |
EASL Studio Podcast: Should anticoagulants be given to patients with cirrhosis to improve outcome?
|
Apr 05, 2022 |
Liver Cancer
|
Mar 24, 2021 |
COVID-19 vaccination in patients with liver disease
|
Mar 17, 2021 |